Jane Street Group, LLC Novo Cure LTD Put Options Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$60.15 - $84.52 $589,470 - $828,296	-9,800 Reduced 13.39%	63,400 $5.25 Million
Q4 2021 Feb 15, 2022	BUY	$75.08 - $121.99 $585,624 - $951,522	7,800 Added 11.93%	73,200 $5.5 Million
Q3 2021 Nov 16, 2021	BUY	$116.17 - $194.55 $4.79 Million - $8.02 Million	41,200 Added 170.25%	65,400 $7.6 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $964,960 - $1.67 Million	-7,400 Reduced 23.42%	24,200 $5.37 Million
Q1 2021 May 18, 2021	SELL	$124.11 - $190.17 $3.51 Million - $5.38 Million	-28,300 Reduced 47.25%	31,600 $4.18 Million
Q4 2020 Feb 17, 2021	BUY	$112.16 - $174.14 $190,672 - $296,038	1,700 Added 2.92%	59,900 $10.4 Million
Q3 2020 Nov 17, 2020	BUY	$58.05 - $111.31 $766,260 - $1.47 Million	13,200 Added 29.33%	58,200 $6.48 Million
Q2 2020 Aug 17, 2020	BUY	$57.2 - $74.41 $2.28 Million - $2.96 Million	39,800 Added 765.38%	45,000 $2.67 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $11,410 - $19,150	-200 Reduced 3.7%	5,200 $350,000
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $348,330 - $478,380	-5,100 Reduced 48.57%	5,400 $455,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $649,530 - $1.03 Million	10,500 New	10,500 $785,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.79B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.